Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Cash from Operations (2023 - 2025)

Historic Cash from Operations for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to -$3.2 million.

  • Onconetix's Cash from Operations fell 17822.13% to -$3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.5 million, marking a year-over-year increase of 4584.74%. This contributed to the annual value of -$10.5 million for FY2024, which is 2268.62% up from last year.
  • As of Q3 2025, Onconetix's Cash from Operations stood at -$3.2 million, which was down 17822.13% from -$1.4 million recorded in Q2 2025.
  • In the past 5 years, Onconetix's Cash from Operations ranged from a high of -$921831.0 in Q4 2024 and a low of -$5.2 million during Q1 2024
  • For the 3-year period, Onconetix's Cash from Operations averaged around -$2.8 million, with its median value being -$3.0 million (2023).
  • In the last 5 years, Onconetix's Cash from Operations skyrocketed by 7862.12% in 2024 and then crashed by 17822.13% in 2025.
  • Quarter analysis of 3 years shows Onconetix's Cash from Operations stood at -$4.3 million in 2023, then soared by 78.62% to -$921831.0 in 2024, then tumbled by 246.05% to -$3.2 million in 2025.
  • Its last three reported values are -$3.2 million in Q3 2025, -$1.4 million for Q2 2025, and -$2.0 million during Q1 2025.